Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma
Nicolas Jacquelot(University of Calgary), Gabrielle T. Belz(The University of Queensland)
Cited by 173
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
|Nature Immunology|2017|639
A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage
|Nature Immunology|2016|365
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
|Cell Research|2019|246
Discrete tissue microenvironments instruct diversity in resident memory T cell function and plasticity
|Nature Immunology|2021|228